Genís Ona - Preliminary efficacy and safety of ibogaine for the treatment of methadone dependence

Ibogaine holds potential as a therapeutic intervention for alleviating the withdrawal symptoms associated with methadone dependence. A pilot phase two clinical trial investigates an administration protocol that uses lower doses of ibogaine to interrupt opiate withdrawal in patients under strict clinical monitoring. Preliminary findings indicate successful mitigation of withdrawal symptoms with no serious adverse effects reported at observed doses. Rigorous safety protocols remain central to this research, incorporating regular EKG monitoring and medical assessments. This study focuses on validating the efficacy of targeted, lower-dose ibogaine sessions while actively addressing the broader challenges of substance use and the necessity of sustainable, ethical research practices.